COMPANY

Medigen, Inc.

HQ: Frederick, MD source · medigen-usa.com ↗ · Mid-Atlantic

Also known as Medigen · 24 sources

Keywords: oncology vaccine infectious disease Venezuelan Equine Encephalitis chikungunya influenza Venezuelan Equine Encephalitis Virus Infection yellow fever prostate cancer V4020

Location: Frederick, MD · source · Oct 14, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)21NIH grants

Timeline

Sep 23, 2025 Grant Government grant — NIH N01: $2.18M (annual award, as published), announced Sep 23, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 23, 2025 Grant Government grant — NIH N01: $2.31M (annual award, as published), announced Sep 23, 2025. Agency: NIH/OD. Source: government award database. source ↗
Aug 15, 2025 Trial start 1: A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers source ↗

Funding

Last 2 years.

Sep 23, 2025 Government grant — NIH N01: $2.18M (annual award, as published), announced Sep 23, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 23, 2025 Government grant — NIH N01: $2.31M (annual award, as published), announced Sep 23, 2025. Agency: NIH/OD. Source: government award database. source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07088822	A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers	1	Not yet recruiting	Aug 15, 2025	Feb 28, 2026 (estimated)

NIH awards 21

Annual award amounts. Total $8.1M.

Feb 13, 2024 NIH award 5U01AI155406-03 FY2024: $562,567 awarded for that fiscal year; activity U01 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Safety and Immunogenicity of novel, live-att source ↗
Mar 27, 2023 NIH award 5U01AI155406-02 FY2023: $604,508 awarded for that fiscal year; activity U01 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Safety and Immunogenicity of novel, live-att source ↗
Mar 1, 2022 NIH award 1U01AI155406-01A1 FY2022: $709,235 awarded for that fiscal year; activity U01 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Safety and Immunogenicity of novel, live-a source ↗
Mar 18, 2021 NIH award 5R43AI152717-02 FY2021: $120,042 awarded for that fiscal year; activity R43 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Novel Chikungunya vaccine with rearranged genome source ↗
Apr 3, 2020 NIH award 1R43AI152717-01 FY2020: $120,759 awarded for that fiscal year; activity R43 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Novel Chikungunya vaccine with rearranged genome source ↗
Mar 4, 2019 NIH award 5R43AI136220-02 FY2019: $95,379 awarded for that fiscal year; activity R43 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Multivalent emergency vaccine against pandemic inf source ↗
Apr 10, 2018 NIH award 1R43AI136220-01A1 FY2018: $95,379 awarded for that fiscal year; activity R43 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Multivalent emergency vaccine against pandemic i source ↗
Jul 20, 2017 NIH award 5R01AI111532-04 FY2017: $383,409 awarded for that fiscal year; activity R01 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Broad-Range VLP Vaccine Against H5N1 Influen source ↗
Jan 27, 2017 NIH award 5R44AI094863-04 FY2017: $812,615 awarded for that fiscal year; activity R44 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Novel DNA-Launched Attenuated Vaccine for VEE Vir source ↗
Jul 15, 2016 NIH award 5R01AI111532-03 FY2016: $392,210 awarded for that fiscal year; activity R01 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Broad-Range VLP Vaccine Against H5N1 Influen source ↗
Jan 27, 2016 NIH award 2R44AI094863-03A1 FY2016: $811,565 awarded for that fiscal year; activity R44 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Novel DNA-Launched Attenuated Vaccine for VEE V source ↗
Jul 30, 2015 NIH award 5R01AI111532-02 FY2015: $400,757 awarded for that fiscal year; activity R01 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Broad-Range VLP Vaccine Against H5N1 Influen source ↗
Aug 12, 2014 NIH award 1R01AI111532-01 FY2014: $350,000 awarded for that fiscal year; activity R01 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Broad-Range VLP Vaccine Against H5N1 Influen source ↗
Aug 6, 2012 NIH award 5R03AI094159-02 FY2012: $87,150 awarded for that fiscal year; activity R03 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. A novel DNA-launched live attenuated Chikungu source ↗
Apr 25, 2012 NIH award 5R43AI094863-02 FY2012: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Novel DNA-Launched Attenuated Vaccine for VEE Vir source ↗
Sep 9, 2011 NIH award 1R03AI094159-01A1 FY2011: $87,150 awarded for that fiscal year; activity R03 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. A novel DNA-launched live attenuated Chikun source ↗
Jul 15, 2011 NIH award 1R43AI094700-01A1 FY2011: $222,146 awarded for that fiscal year; activity R43 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Trivalent Arenaviral Vaccine Based on Virus-Lik source ↗
May 25, 2011 NIH award 1R43AI094863-01 FY2011: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Novel DNA-Launched Attenuated Vaccine for VEE Vir source ↗
Jan 6, 2011 NIH award 1R43AI088923-01A1 FY2011: $117,986 awarded for that fiscal year; activity R43 (SBIR); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. Infectious DNA (i-DNA) Vaccine for Yellow Fever source ↗
2011 NIH contract (government contract; not a grant and not an investment round) 261201100088C-0-0-1 FY2011: $1,483,094 awarded for that fiscal year; activity N44 (OTHER_NIH); PI PUSHKO, PETER; recipient as written: MEDIGEN, INC., FREDERICK, MD. SBIR TOPIC 255, PHA source ↗
2009 NIH contract (government contract; not a grant and not an investment round) 261200900060C-0-0-1 FY2009: $89,871 awarded for that fiscal year; activity N43 (OTHER_NIH); PI PUSHKO, PETER M.; recipient as written: MEDIGEN, INC., FREDERICK, MD. SBIR TOPIC 255 source ↗